Market revenue in 2020 | USD 46.6 million |
Market revenue in 2028 | USD 133.7 million |
Growth rate | 14.1% (CAGR from 2020 to 2028) |
Largest segment | Standard chemotherapy |
Fastest growing segment | Targeted Therapy |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Standard Chemotherapy, Targeted Therapy |
Key market players worldwide | Novartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.
Standard chemotherapy was the largest segment with a revenue share of 59.01% in 2020. Horizon Databook has segmented the Brazil stomach cancer treatment market based on standard chemotherapy, targeted therapy covering the revenue growth of each sub-segment from 2018 to 2028.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil stomach cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Brazil stomach cancer treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account